Sakar Healthcare surged 8.49% to Rs 408.95 after the company’s oncology unit has attained EU GMP approval valid for three years from the audit date of 5th March 2024.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
Sakar Healthcare surged 8.49% to Rs 408.95 after the company’s oncology unit has attained EU GMP approval valid for three years from the audit date of 5th March 2024.
| Subscribe To Our Free Newsletter |
